Discover Tenders by Dosage Kits Sector

Find the most relevant tenders for Dosage Kits. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Dosage Kits tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Dosage Kits tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For Ws Lanthanum Iii Carbonate In The Dosage Form Of Chewable Tablets Atc Code According To Who V0

Deadline: 31 Jul 2026

Germany

Ref. No.: 6417253

EMD:Ref Document

Bid Value: Ref Document

117 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Olanzapine Excl Dafo For The Production Of A Depot Isu Atc N05Ah03 Obo For The Period 01 08 24 31 07 26

Deadline: 05 Jun 2026

Germany

Ref. No.: 6373800

EMD:Ref Document

Bid Value: Ref Document

61 Days Left

Medicines Containing The Active Ingredient Lanthanum Iii Carbonate Atc V03Ae03 In The Dosage Form Chewable Tablets

Deadline: 31 May 2026

Germany

Ref. No.: 6371060

EMD:Ref Document

Bid Value: Ref Document

56 Days Left

Medicines Containing The Active Ingredient Lanthanum Iii Carbonate Atc V03Ae03 In The Dosage Form Chewable Tablets

Deadline: 31 May 2026

Germany

Ref. No.: 6321582

EMD:Ref Document

Bid Value: Ref Document

56 Days Left

Open House Discount Contracts 2024 08

Deadline: 31 Jul 2026

Germany

Ref. No.: 6307709

EMD:Ref Document

Bid Value: Ref Document

117 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Fentanyl In The Dosage Form Of Sublingual Tablets Atc Code According To Wh

Deadline: 30 Jun 2026

Germany

Ref. No.: 6165516

EMD:Ref Document

Bid Value: Ref Document

86 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Betamethasone And Calcipotriol In All Dosage Forms Except Ointments Atc Code D05Ax2

Deadline: 27 May 2026

Germany

Ref. No.: 6157193

EMD:Ref Document

Bid Value: Ref Document

52 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Epinephrine In The Dosage Form Ilo

Deadline: 10 May 2026

Germany

Ref. No.: 5978859

EMD:Ref Document

Bid Value: Ref Document

35 Days Left

Conclusion Not Exclusive Of Am Discount Agreement According To Section 130A Paragraph 8 Sgb V By Means Of An Oh Model For Ws Epoetin Alfa Genetically Engineered Human Erythropoietin Restriction To Packs With Doses Up To 10 000 Iu

Deadline: 31 Jul 2026

Germany

Ref. No.: 5978748

EMD:Ref Document

Bid Value: Ref Document

117 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ebastine In The Strength 20 Mg And The Dosage Form Smt

Deadline: 10 May 2026

Germany

Ref. No.: 5978310

EMD:Ref Document

Bid Value: Ref Document

35 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brimonidine In The Dosage Form Edp

Deadline: 10 May 2026

Germany

Ref. No.: 5977462

EMD:Ref Document

Bid Value: Ref Document

35 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf

Deadline: 10 May 2026

Germany

Ref. No.: 5976401

EMD:Ref Document

Bid Value: Ref Document

35 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage Form Lse

Deadline: 10 May 2026

Germany

Ref. No.: 5968352

EMD:Ref Document

Bid Value: Ref Document

35 Days Left

Medicines With The Active Ingredient Rivaroxaban Atc B01Af01 In All Potencies Except 2 5 Mg Per Divided Oral Dosage Form

Deadline: 30 Apr 2026

Germany

Ref. No.: 5771252

EMD:Ref Document

Bid Value: Ref Document

25 Days Left

Medicines With The Active Ingredient Rivaroxaban Atc B01Af01 With A Potency Of 2 5 Mg Per Divided Oral Dosage Form

Deadline: 30 Apr 2026

Germany

Ref. No.: 5769473

EMD:Ref Document

Bid Value: Ref Document

25 Days Left

Showing 8086 to 8100 of 8110 results

Discover Tenders by Dosage Kits Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Dosage Kits Sector

Filter Your Search

FREE Trial plan for all new users!